Sanofi Genzyme is expanding its Multiple Myeloma Journey Partners Program, which uses storytelling as a tool to help multiple myeloma patients and caregivers.
"Sanofi Genzyme created the Multiple Myeloma Journey Partners
Program to let multiple myeloma patients know they are not alone and to provide
educational resources and services that help patients and families navigate
their journey to achieve the best possible outcomes," Sanofi Genzyme Vice
President and General Manager of US Oncology Bhavesh Ashar said in a press release."As a
company, we value the importance of taking a holistic approach to patient care
and transforming the patient experience. There's a real power in telling and
listening to personal narratives. It helps increase the knowledge base of
patients and caregivers and makes them feel supported."
The peer-to-peer education program is a free one-hour
educational seminar. Journey Partners share their experiences when they
underwent autologous stem cell transplants (ASCT) with other patients and
caregivers. The session also provides resources and encourages patients to consider
ASCT evaluations, according to the release.
"It was conversations with my support group, family and
healthcare providers that influenced my decision to have a stem cell transplant
in 2008 when I was first diagnosed with multiple myeloma at the age of 65,"
Multiple Myeloma Journey Partner John Killip said. " Mentoring other
myeloma patients is one of the highlights of my life and I became a Journey
Partner to share my story and help others with multiple myeloma make sense of
the diagnosis and overcome the fear of the unknown."
Multiple Myeloma Journey Partners Program to expand
Organizations in this Story
Want to get notified whenever we write about Genzyme Corporation ?
Next time we write about Genzyme Corporation, we'll email you a link to the story. You may edit your settings or unsubscribe at any time.Sign-up for Alerts